{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:47:57Z","timestamp":1794664077555,"version":"4.9.1"},"reference-count":137,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00727"],"award-info":[{"award-number":["PI18\/00727"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00579"],"award-info":[{"award-number":["PI20\/00579"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2017SGR\u201001281"],"award-info":[{"award-number":["2017SGR\u201001281"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["668031"],"award-info":[{"award-number":["668031"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["731875"],"award-info":[{"award-number":["731875"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825694"],"award-info":[{"award-number":["825694"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847949"],"award-info":[{"award-number":["847949"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["403224013 \u2013 SFB 1382 (A09)"],"award-info":[{"award-number":["403224013 \u2013 SFB 1382 (A09)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with decompensated cirrhosis experience high mortality rates. Current prognostic scores, including the model for end-stage liver disease (MELD), may underperform in settings other than in those they were initially developed. Novel biomarkers have been proposed to improve prognostication accuracy and even to predict development of complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review and meta-analysis on novel urine and blood biomarkers and their ability to predict 90-day mortality in patients with decompensated cirrhosis. Secondary outcomes included 28-day and 1-year mortality, and development of acute-on-chronic liver failure, acute kidney injury and other complications. To overcome differences in units, temporal changes in assays and reporting heterogeneity, we used the ratio of means (RoM) as measure of association for assessing strength in predicting outcomes. An RoM&gt;1 implies that the mean biomarker level is higher in those that develop the outcome than in those that do not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 6629 unique references, 103 were included, reporting on 29 different biomarkers, with a total of 31\u2009362 biomarker patients. Most studies were prospective cohorts of hospitalised patients (median Child-Pugh-Turcotte score of 9 and MELD score of 18). The pooled 90-day mortality rate was 0.27 (95% CI 0.24 to 0.29). The RoM for predicting 90-day mortality was highest for interleukin 6 (IL-6) (2.56, 95% CI 2.39 to 2.74), followed by urinary neutrophil gelatinase-associated lipocalin (uNGAL) (2.42, 95% CI 2.20 to 2.66) and copeptin (2.33, 95% CI 2.17 to 2.50). These RoMs were all higher than for MELD (1.44, 95% CI 1.42 to 1.46).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Novel biomarkers, including IL-6, uNGAL and copeptin, can probably improve prognostication of patients with decompensated cirrhosis compared with MELD alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-329923","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T13:20:15Z","timestamp":1698326415000},"page":"156-165","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4832-5130","authenticated-orcid":false,"given":"Adri\u00e0","family":"Juanola","sequence":"first","affiliation":[{"name":"Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain"},{"name":"Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Thu","family":"Ma","sequence":"additional","affiliation":[{"name":"Toronto Centre for Liver Disease Francis Family Liver Clinic, Toronto General Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-8549","authenticated-orcid":false,"given":"Koos","family":"de Wit","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohilan","family":"Gananandan","sequence":"additional","affiliation":[{"name":"Institute for Liver and Digestive Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Roux","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Beaujon Hospital, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3219-6963","authenticated-orcid":false,"given":"Giacomo","family":"Zaccherini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-related Diseases, University of Bologna Hospital of Bologna Sant'Orsola-Malpighi Polyclinic, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-2048","authenticated-orcid":false,"given":"C\u00e9sar","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tonon","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sol\u00e9","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Consorci Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Villaseca","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank E","family":"Uschner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, University of M\u00fcnster, Munster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-9784","authenticated-orcid":false,"given":"Isabel","family":"Graupera","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain"},{"name":"Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pose","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain"},{"name":"Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Moreta","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Campion","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[{"name":"Gastroenterology & Hepatology, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshawar P","family":"Mookerjee","sequence":"additional","affiliation":[{"name":"Institute of Liver and Digestive Health, University College London Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Beaujon Hospital, Clichy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Durand","sequence":"additional","affiliation":[{"name":"DHU Unity, P\u00f4le des Maladies de l\u2019Appareil Digestif, Service d'H\u00e9patologie, Centre de R\u00e9f\u00e9rence des Maladies Vasculaires du Foie, H\u00f4pital Beaujon, AP-HP, Clichy, France"},{"name":"Universit\u00e9 Denis Diderot-Paris 7, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Vargas","sequence":"additional","affiliation":[{"name":"Liver Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-5830","authenticated-orcid":false,"given":"Salvatore","family":"Piano","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Alonso","sequence":"additional","affiliation":[{"name":"Digestive Disease Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, University of M\u00fcnster, Munster, Germany"},{"name":"European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Laleman","sequence":"additional","affiliation":[{"name":"Division of Liver and Biliopanreatic Disorders, KU Leuven, University of Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet K","family":"Asrani","sequence":"additional","affiliation":[{"name":"Division of Hepatology, Department of Medicine, Baylor University Medical Center at Dallas, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Soriano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alessandria","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Serra-Burriel","sequence":"additional","affiliation":[{"name":"University of Zurich Institute of Epidemiology Biostatistics and Prevention, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morales-Ruiz","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Department-CDB, Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-7913","authenticated-orcid":false,"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[{"name":"Biostatistics and Data Management Core Facility, IDIBAPS, Hospital Clinic Barcelona, Barcelona, Spain"},{"name":"Biostatistics Unit, Faculty of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S","family":"Allegretti","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-4932","authenticated-orcid":false,"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Odense University Hospital, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Watson","sequence":"additional","affiliation":[{"name":"Evotec ID (Lyon) SAS, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G","family":"Abraldes","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology (Liver Unit), University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Kamath","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Mayo Medical School, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-4020","authenticated-orcid":false,"given":"Ruben","family":"Hernaez","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA"},{"name":"Gastroenterology and Hepatology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain"},{"name":"Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain"},{"name":"Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas, Barcelona, Spain"},{"name":"Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"2025112102451143000_73.1.156.1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"The Lancet"},{"key":"2025112102451143000_73.1.156.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.042"},{"key":"2025112102451143000_73.1.156.3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"2025112102451143000_73.1.156.4","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09946-3"},{"key":"2025112102451143000_73.1.156.5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025112102451143000_73.1.156.6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312670"},{"key":"2025112102451143000_73.1.156.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040313"},{"key":"2025112102451143000_73.1.156.8","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172"},{"key":"2025112102451143000_73.1.156.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.02.010"},{"key":"2025112102451143000_73.1.156.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.08.050"},{"key":"2025112102451143000_73.1.156.11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/TP.0000000000002997","article-title":"Patients with persistently low MELD-NA scores continue to be at risk of liver-related death","volume":"104","author":"Mazumder","year":"2020","journal-title":"Transplantation"},{"key":"2025112102451143000_73.1.156.12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jhep.2020.06.005","article-title":"Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure","volume":"73","author":"Hernaez","year":"2020","journal-title":"Journal of Hepatology"},{"key":"2025112102451143000_73.1.156.13","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.cgh.2019.01.042","article-title":"Validation of a model for identification of patients with compensated cirrhosis at high risk of decompensation","volume":"17","author":"Guha","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.14","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113989"},{"key":"2025112102451143000_73.1.156.15","unstructured":"FDA-NIH Biomarker Working Group. FDA-NIH Biomarker Working Group. BEST FDA-NIH Biomarker Working Group . BEST (Biomarkers, EndpointS, and other Tools)(Biomarkers, EndpointS, and other Tools). Bethesd (MD): National Institutes of Health (US): Silver Spring (MD): Food and Drug Administration (US), 2016."},{"key":"2025112102451143000_73.1.156.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2025112102451143000_73.1.156.17","unstructured":"Juanola A , Ma AT , Pose E , et al . Biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. PROSPERO 2021 Crd42021250226. n.d. Available: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021250226"},{"key":"2025112102451143000_73.1.156.18","unstructured":"Veritas Health Innovation . Covidence systematic review software. n.d. Available: www.covidence.org"},{"key":"2025112102451143000_73.1.156.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2025112102451143000_73.1.156.20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-6-200603210-00010"},{"key":"2025112102451143000_73.1.156.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.016"},{"key":"2025112102451143000_73.1.156.22","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"2025112102451143000_73.1.156.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.06.012"},{"key":"2025112102451143000_73.1.156.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.11.012"},{"key":"2025112102451143000_73.1.156.25","doi-asserted-by":"crossref","unstructured":"Higgins JPT , Thomas J , Chandler J , et al . Cochrane handbook for systematic reviews of interventions version. 2019: 6. doi:10.1002\/9781119536604","DOI":"10.1002\/9781119536604"},{"key":"2025112102451143000_73.1.156.26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/liv.13264","article-title":"High serum Lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis","volume":"37","author":"Agiasotelli","year":"2017","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.27","doi-asserted-by":"crossref","unstructured":"Ahn HS , Kim YS , Kim SG , et al . Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels. HGE 2011. doi:10.5754\/hge11616","DOI":"10.5754\/hge11616"},{"key":"2025112102451143000_73.1.156.28","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000382","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Weng","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"2025112102451143000_73.1.156.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"key":"2025112102451143000_73.1.156.30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J Hepatol"},{"key":"2025112102451143000_73.1.156.31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2152\/jmi.68.302","article-title":"Plasma cystatin C level is a prognostic marker of morbidity and mortality in hospitalized decompensated Cirrhotic patients","volume":"68","author":"Aumpan","year":"2021","journal-title":"J Med Invest"},{"key":"2025112102451143000_73.1.156.32","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/hep.31798","article-title":"Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications","volume":"74","author":"Baldassarre","year":"2021","journal-title":"Hepatology"},{"key":"2025112102451143000_73.1.156.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.023"},{"key":"2025112102451143000_73.1.156.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.02.013"},{"key":"2025112102451143000_73.1.156.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02219.x"},{"key":"2025112102451143000_73.1.156.36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhepr.2019.06.002","article-title":"Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF","volume":"1","author":"Blasi","year":"2019","journal-title":"JHEP Rep"},{"key":"2025112102451143000_73.1.156.37","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.13095","article-title":"The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection","volume":"36","author":"Bruns","year":"2016","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.38","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90361-F"},{"key":"2025112102451143000_73.1.156.39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jvh.13100","article-title":"Serum Keratin\u201018 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B Virus\u2010related cirrhosis","volume":"26","author":"Cao","year":"2019","journal-title":"J Viral Hepat"},{"key":"2025112102451143000_73.1.156.40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-85148-y","article-title":"Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients","volume":"11","author":"Cardoso","year":"2021","journal-title":"Sci Rep"},{"key":"2025112102451143000_73.1.156.41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcma.2013.10.006","article-title":"Lipopolysaccharide binding protein in cirrhotic patients with severe sepsis","volume":"77","author":"Chen","year":"2014","journal-title":"J Chin Med Assoc"},{"key":"2025112102451143000_73.1.156.42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3350\/kjhep.2010.16.3.301","article-title":"Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis","volume":"16","author":"Chung","year":"2010","journal-title":"Korean J Hepatol"},{"key":"2025112102451143000_73.1.156.43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28740"},{"key":"2025112102451143000_73.1.156.44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4254\/wjh.v8.i17.739","article-title":"Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis","volume":"8","author":"Correa","year":"2016","journal-title":"World J Hepatol"},{"key":"2025112102451143000_73.1.156.45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol"},{"key":"2025112102451143000_73.1.156.46","first-page":"487","article-title":"Von-Willebrand factor as a Predictor of three-month mortality in patients with liver cirrhosis compared to MELD score","volume":"82","author":"Curakova Ristovska","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"2025112102451143000_73.1.156.47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4254\/wjh.v14.i4.812","article-title":"Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators","volume":"14","author":"Curakova Ristovska","year":"2022","journal-title":"World J Hepatol"},{"key":"2025112102451143000_73.1.156.48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.839250","article-title":"Urinary neutrophil Gelatinase-associated Lipocalin can predict the efficacy of volume expansion therapy in patients with hepatitis B cirrhosis and AKI","volume":"13","author":"Duan","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025112102451143000_73.1.156.49","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2867241","article-title":"Evaluation of the biomarkers Hmgb1 and IL-6 as predictors of mortality in cirrhotic patients with acute kidney injury","volume":"2020","author":"de Oliveira Gomes","year":"2020","journal-title":"Mediators Inflamm"},{"key":"2025112102451143000_73.1.156.50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10753-021-01565-1","article-title":"Performance of high mobility protein group 1 and Interleukin-6 as predictors of outcomes resulting from variceal bleeding in patients with advanced chronic liver disease","volume":"45","author":"Dos Santos Pinheiro","year":"2022","journal-title":"Inflammation"},{"key":"2025112102451143000_73.1.156.51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00134-007-0864-z","article-title":"Hyperreninemic hypoaldosteronism syndrome, plasma concentrations of Interleukin-6 and outcome in critically ill patients with liver cirrhosis","volume":"34","author":"du Cheyron","year":"2008","journal-title":"Intensive Care Med"},{"key":"2025112102451143000_73.1.156.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.015"},{"key":"2025112102451143000_73.1.156.53","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14811","article-title":"Value of shear wave elastography in predicting Hepatorenal syndrome in patients with liver cirrhosis and Ascites","volume":"75","author":"Fang","year":"2021","journal-title":"Int J Clin Pract"},{"key":"2025112102451143000_73.1.156.54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25806"},{"key":"2025112102451143000_73.1.156.55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cyto.2016.12.017","article-title":"From stable disease to acute-on-chronic liver failure: circulating cytokines are related to prognosis in different stages of cirrhosis","volume":"91","author":"Fischer","year":"2017","journal-title":"Cytokine"},{"key":"2025112102451143000_73.1.156.56","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/hep.32799","article-title":"Diagnostic and prognostic performance of urinary neutrophil Gelatinase\u2010Associated Lipocalin in patients with cirrhosis and acute kidney injury","volume":"77","author":"Gambino","year":"2023","journal-title":"Hepatology"},{"key":"2025112102451143000_73.1.156.57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157371","article-title":"Urine monocyte chemoattractant Protein-1 is an independent predictive factor of hospital readmission and survival in cirrhosis","volume":"11","author":"Graupera","year":"2016","journal-title":"PLoS One"},{"key":"2025112102451143000_73.1.156.58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01709-0","article-title":"Adipocyte fatty-acid binding protein is overexpressed in cirrhosis and correlates with clinical outcomes","volume":"7","author":"Graupera","year":"2017","journal-title":"Sci Rep"},{"key":"2025112102451143000_73.1.156.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.021"},{"key":"2025112102451143000_73.1.156.60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jgh.15125","article-title":"Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute\u2010on\u2010chronic liver failure and acute decompensation","volume":"36","author":"Gr\u00f8nbaek","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.31047","article-title":"The von Willebrand factor facilitates model for end\u2010stage liver disease\u2013independent risk stratification on the waiting list for liver transplantation","volume":"72","author":"Gy\u00f6ri","year":"2020","journal-title":"Hepatology"},{"key":"2025112102451143000_73.1.156.62","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s12072-021-10203-9","article-title":"The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes","volume":"15","author":"Hartl","year":"2021","journal-title":"Hepatol Int"},{"key":"2025112102451143000_73.1.156.63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/hepr.12355","article-title":"Interleukin-1 receptor antagonist correlates with hepatic venous pressure gradient and predicts occurrence of overall complications and bacterial infections in patients with cirrhosis","volume":"45","author":"Hsieh","year":"2015","journal-title":"Hepatol Res"},{"key":"2025112102451143000_73.1.156.64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30592"},{"key":"2025112102451143000_73.1.156.65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cgh.2021.07.012","article-title":"Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death","volume":"20","author":"Jachs","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.66","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1038\/s41598-019-51053-8","article-title":"Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis","volume":"9","author":"Jo","year":"2019","journal-title":"Sci Rep"},{"key":"2025112102451143000_73.1.156.67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jhep.2021.08.031","article-title":"Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis","volume":"76","author":"Juanola","year":"2022","journal-title":"J Hepatol"},{"key":"2025112102451143000_73.1.156.68","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2016.06.002","article-title":"Von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia","volume":"65","author":"Kalambokis","year":"2016","journal-title":"J Hepatol"},{"key":"2025112102451143000_73.1.156.69","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jmii.2015.03.001","article-title":"IL-6 significantly correlates with P-Stat3 expression and presents high Variceal bleeding with mortality in Cirrhotic patients: A cross-sectional study","volume":"50","author":"Kao","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"2025112102451143000_73.1.156.70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138264","article-title":"Copeptin as an indicator of hemodynamic derangement and prognosis in liver cirrhosis","volume":"10","author":"Kerbert","year":"2015","journal-title":"PLoS One"},{"key":"2025112102451143000_73.1.156.71","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-017-1894-8","article-title":"Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival","volume":"21","author":"Kerbert","year":"2017","journal-title":"Crit Care"},{"key":"2025112102451143000_73.1.156.72","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1111\/liv.14631","article-title":"Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: a multicentre prospective study","volume":"40","author":"Kim","year":"2020","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/ijn.IJN_254_19","article-title":"Utility of urinary neutrophil Gelatinase associated Lipocalin (NGAL) in decompensated cirrhosis","volume":"30","author":"Krishna Reddy","year":"2020","journal-title":"Indian J Nephrol"},{"key":"2025112102451143000_73.1.156.74","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.235689"},{"key":"2025112102451143000_73.1.156.75","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/apt.15515","article-title":"Raised serum interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy","volume":"50","author":"Labenz","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025112102451143000_73.1.156.76","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80155-2"},{"key":"2025112102451143000_73.1.156.77","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29581"},{"key":"2025112102451143000_73.1.156.78","doi-asserted-by":"crossref","DOI":"10.1038\/srep40157","article-title":"Lipopolysaccharide-induced neutrophil dysfunction following transjugular intrahepatic portosystemic stent shunt (TIPSS) insertion is associated with organ failure and mortality","volume":"7","author":"Macnaughtan","year":"2017","journal-title":"Sci Rep"},{"key":"2025112102451143000_73.1.156.79","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12072-017-9822-1","article-title":"AKI persistence at 48 H predicts mortality in patients with acute on chronic liver failure","volume":"11","author":"Maiwall","year":"2017","journal-title":"Hepatol Int"},{"key":"2025112102451143000_73.1.156.80","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12072-022-10426-4","article-title":"PIRO-CIC model can predict mortality and futility of care in critically ill cirrhosis patients in the intensive care unit","volume":"17","author":"Maiwall","year":"2023","journal-title":"Hepatol Int"},{"key":"2025112102451143000_73.1.156.81","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14522"},{"key":"2025112102451143000_73.1.156.82","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.29290","article-title":"Plasma Cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"key":"2025112102451143000_73.1.156.83","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/TP.0000000000003222","article-title":"Cystatin C and sarcopenia predict acute on chronic liver failure development and mortality in patients on the liver transplant waiting list","volume":"104","author":"Mauro","year":"2020","journal-title":"Transplantation"},{"key":"2025112102451143000_73.1.156.84","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24043"},{"key":"2025112102451143000_73.1.156.85","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/liv.12175","article-title":"Plasma copeptin, a possible prognostic marker in cirrhosis","volume":"33","author":"Moreno","year":"2013","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.86","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep4.1963","article-title":"Patterns of kidney dysfunction in acute-on-chronic liver failure: relationship with kidney and patients\u2019 outcome","volume":"6","author":"Napoleone","year":"2022","journal-title":"Hepatol Commun"},{"key":"2025112102451143000_73.1.156.87","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270507"},{"key":"2025112102451143000_73.1.156.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.06.013"},{"key":"2025112102451143000_73.1.156.89","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jgh3.12516","article-title":"Cystatin C and Interleukin\u20106 for prognosticating patients with acute decompensation of cirrhosis","volume":"5","author":"Padia","year":"2021","journal-title":"JGH Open"},{"key":"2025112102451143000_73.1.156.90","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/0886022X.2020.1801468","article-title":"Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? \u2013 preliminary study","volume":"42","author":"Pietrukaniec","year":"2020","journal-title":"Ren Fail"},{"key":"2025112102451143000_73.1.156.91","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14433"},{"key":"2025112102451143000_73.1.156.92","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14474"},{"key":"2025112102451143000_73.1.156.93","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50447"},{"key":"2025112102451143000_73.1.156.94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200644","article-title":"Monocyte human leukocyte antigen \u2013 antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure","volume":"13","author":"Satsangi","year":"2018","journal-title":"PLoS One"},{"key":"2025112102451143000_73.1.156.95","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1515\/cclm-2019-0023","article-title":"Copeptin \u2013 a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease","volume":"57","author":"Schneider","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2025112102451143000_73.1.156.96","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hep4.1303","article-title":"IL\u201022 and IL\u201022\u2010binding protein are associated with development of and mortality from Acute\u2010On\u2010Chronic liver failure","volume":"3","author":"Schwarzkopf","year":"2019","journal-title":"Hepatol Commun"},{"key":"2025112102451143000_73.1.156.97","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jgh.13983","article-title":"Serum cystatin C level: an excellent predictor of mortality in patients with cirrhotic ascites","volume":"33","author":"Seo","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02105.x"},{"key":"2025112102451143000_73.1.156.99","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12072-011-9266-y","article-title":"Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis","volume":"5","author":"Sharawey","year":"2011","journal-title":"Hepatol Int"},{"key":"2025112102451143000_73.1.156.100","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12299"},{"key":"2025112102451143000_73.1.156.101","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jhep.2016.07.003","article-title":"Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis","volume":"65","author":"Sol\u00e0","year":"2016","journal-title":"J Hepatol"},{"key":"2025112102451143000_73.1.156.102","doi-asserted-by":"publisher","DOI":"10.1038\/srep32341"},{"key":"2025112102451143000_73.1.156.103","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14037"},{"key":"2025112102451143000_73.1.156.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.04.028"},{"key":"2025112102451143000_73.1.156.105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1744-9987.12024","article-title":"Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure","volume":"18","author":"Stauber","year":"2014","journal-title":"Ther Apher Dial"},{"key":"2025112102451143000_73.1.156.106","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012342929326"},{"key":"2025112102451143000_73.1.156.107","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00042737-200406000-00010","article-title":"Nitric oxide in ascitic fluid is an independent predictor of the development of renal impairment in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"16","author":"Such","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.108","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jgh3.12543","article-title":"Serum cystatin C as a predictor of 90\u2010day mortality among patients admitted with complications of cirrhosis","volume":"5","author":"Suksamai","year":"2021","journal-title":"JGH Open"},{"key":"2025112102451143000_73.1.156.109","first-page":"1487","article-title":"CLIF-SOFA and urine neutrophil Gelatinase-associated Lipocalin score for the diagnosis of acute-on-chronic liver failure and as a Prognostic tool for mortality prediction","volume":"101","author":"Teerasarntipan","year":"2018","journal-title":"J Med Assoc Thai"},{"key":"2025112102451143000_73.1.156.110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2478\/s11536-013-0287-x","article-title":"Prognostic value of serum Cystatin C levels in cirrhotic patients with normal serum creatinine","volume":"9","author":"Teneva","year":"2014","journal-title":"Open Med"},{"key":"2025112102451143000_73.1.156.111","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1440-1746.2012.07188.x","article-title":"High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients","volume":"27","author":"Thevenot","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.112","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/liv.13133","article-title":"Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection","volume":"36","author":"Tornai","year":"2016","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.113","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/liv.14230","article-title":"Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS","volume":"40","author":"Torner","year":"2020","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.114","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-015-0372-5","article-title":"Urine neutrophil Gelatinase-associated Lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized Cirrhotic patients with AKI-prone conditions","volume":"15","author":"Treeprasertsuk","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"2025112102451143000_73.1.156.115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1440-1746.2012.07288.x","article-title":"Acute renal failure in cirrhotic patients with severe sepsis: value of urinary Interleukin-18","volume":"28","author":"Tsai","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2025112102451143000_73.1.156.116","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jgh3.12377","article-title":"Urinary neutrophil Gelatinase\u2010Associated Lipocalin determines short\u2010term mortality and type of acute kidney injury in cirrhosis","volume":"4","author":"Udgirkar","year":"2020","journal-title":"JGH Open"},{"key":"2025112102451143000_73.1.156.117","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2013.01.005","article-title":"Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis","volume":"58","author":"Waidmann","year":"2013","journal-title":"J Hepatol"},{"key":"2025112102451143000_73.1.156.118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1042\/cs0980419","article-title":"Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection","volume":"98","author":"Wang","year":"2000","journal-title":"Clin Sci"},{"key":"2025112102451143000_73.1.156.119","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/liv.13916","article-title":"Circulating levels of 3-hydroxymyristate, a direct quantification of endotoxaemia in noninfected Cirrhotic patients","volume":"39","author":"Weil","year":"2019","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.120","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/liv.12428","article-title":"Cardiac and proinflammatory markers predict prognosis in cirrhosis","volume":"34","author":"Wiese","year":"2014","journal-title":"Liver Int"},{"key":"2025112102451143000_73.1.156.121","article-title":"Serum Cystatin C predicts mortality in HBV-related decompensated cirrhosis","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed Res Int"},{"key":"2025112102451143000_73.1.156.122","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.krcp.2015.08.003","article-title":"Early predictors of acute kidney injury in patients with cirrhosis and bacterial infection: urinary neutrophil Gelatinase-associated Lipocalin and cardiac output as reliable tools","volume":"34","author":"Ximenes","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"2025112102451143000_73.1.156.123","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.dld.2016.11.001","article-title":"Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis","volume":"49","author":"Yap","year":"2017","journal-title":"Dig Liver Dis"},{"key":"2025112102451143000_73.1.156.124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.33879\/AMH.134.2021.06047","article-title":"Serum Cystatin C as a Predictor of mortality in elderly patients with liver cirrhosis and normal serum creatinine","volume":"13","author":"Zaki","year":"2022","journal-title":"Aging Med Healthc"},{"key":"2025112102451143000_73.1.156.125","first-page":"8","article-title":"Soluble CD163 is a predictor of mortality in patients with decompensated cirrhosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"2025112102451143000_73.1.156.126","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/joim.12054","article-title":"Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality","volume":"274","author":"Zimmermann","year":"2013","journal-title":"J Intern Med"},{"key":"2025112102451143000_73.1.156.127","first-page":"399","article-title":"Serum endocan level in diabetes mellitus of patients with cirrhosis and risk of subsequent development of spontaneous bacterial Peritonitis","volume":"70","author":"Zuwala-Jagiello","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"2025112102451143000_73.1.156.128","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"2025112102451143000_73.1.156.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.029"},{"key":"2025112102451143000_73.1.156.130","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318843"},{"key":"2025112102451143000_73.1.156.131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.013"},{"key":"2025112102451143000_73.1.156.132","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00070-3"},{"key":"2025112102451143000_73.1.156.133","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322161"},{"key":"2025112102451143000_73.1.156.134","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025112102451143000_73.1.156.135","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"2025112102451143000_73.1.156.136","doi-asserted-by":"publisher","DOI":"10.7326\/L15-5093"},{"key":"2025112102451143000_73.1.156.137","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/lt.26390","article-title":"Proposing a framework to assess the methodological quality of prognostic models","volume":"28","author":"Hernaez","year":"2022","journal-title":"Liver Transpl"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-329923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T10:45:29Z","timestamp":1763721929000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-329923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/gutjnl-2023-329923"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-329923","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}